Cargando…
Updated total IgE reference intervals in Norwegian adults
BACKGROUND: It is important and expected of laboratories to provide updated reference intervals to the clinician. As no recent publications report adult total IgE reference intervals on a Scandinavian population, the aim of our study was therefore to provide an estimate on healthy Norweigian adults....
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9753806/ https://www.ncbi.nlm.nih.gov/pubmed/36705407 http://dx.doi.org/10.1002/iid3.751 |
_version_ | 1784851045615140864 |
---|---|
author | Vinnes, Erik Wilhelm Skarbø, Birthe Wentzel‐Larsen, Tore Sylte, Marit S. Apelseth, Torunn Oveland |
author_facet | Vinnes, Erik Wilhelm Skarbø, Birthe Wentzel‐Larsen, Tore Sylte, Marit S. Apelseth, Torunn Oveland |
author_sort | Vinnes, Erik Wilhelm |
collection | PubMed |
description | BACKGROUND: It is important and expected of laboratories to provide updated reference intervals to the clinician. As no recent publications report adult total IgE reference intervals on a Scandinavian population, the aim of our study was therefore to provide an estimate on healthy Norweigian adults. METHODS: A reference interval study was conducted in accordance to CLSI guidelines. Samples were collected from n = 252 presumably healthy adult participants enrolled through the regional blood donation program. Total IgE measurements were performed on the ImmunoCAP(TM) platform (Thermo Fisher Diagnostics) traceable to the WHO‐reference standard (75/502) for total IgE measurements. RESULTS: An upper 95% total IgE reference limit was estimated to 302 kU/L (90% CI 177–388 kU/L), and the 97.5% percentile was estimated to 391 kU/L (90% CI 344–560 kU/L). No significant differences were found between participants who self‐reported having an allergic disease and participants who did not self‐report having an allergic disease. CONCLUSION: Our results and other recent publications find markedly higher values than adult reference intervals established four decades ago which still remain widely used by clinical laboratories. We therefore recommend total IgE reference intervals should be critically reviewed and updated. |
format | Online Article Text |
id | pubmed-9753806 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-97538062022-12-19 Updated total IgE reference intervals in Norwegian adults Vinnes, Erik Wilhelm Skarbø, Birthe Wentzel‐Larsen, Tore Sylte, Marit S. Apelseth, Torunn Oveland Immun Inflamm Dis Short Reports BACKGROUND: It is important and expected of laboratories to provide updated reference intervals to the clinician. As no recent publications report adult total IgE reference intervals on a Scandinavian population, the aim of our study was therefore to provide an estimate on healthy Norweigian adults. METHODS: A reference interval study was conducted in accordance to CLSI guidelines. Samples were collected from n = 252 presumably healthy adult participants enrolled through the regional blood donation program. Total IgE measurements were performed on the ImmunoCAP(TM) platform (Thermo Fisher Diagnostics) traceable to the WHO‐reference standard (75/502) for total IgE measurements. RESULTS: An upper 95% total IgE reference limit was estimated to 302 kU/L (90% CI 177–388 kU/L), and the 97.5% percentile was estimated to 391 kU/L (90% CI 344–560 kU/L). No significant differences were found between participants who self‐reported having an allergic disease and participants who did not self‐report having an allergic disease. CONCLUSION: Our results and other recent publications find markedly higher values than adult reference intervals established four decades ago which still remain widely used by clinical laboratories. We therefore recommend total IgE reference intervals should be critically reviewed and updated. John Wiley and Sons Inc. 2022-12-15 /pmc/articles/PMC9753806/ /pubmed/36705407 http://dx.doi.org/10.1002/iid3.751 Text en © 2022 The Authors. Immunity, Inflammation and Disease published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Short Reports Vinnes, Erik Wilhelm Skarbø, Birthe Wentzel‐Larsen, Tore Sylte, Marit S. Apelseth, Torunn Oveland Updated total IgE reference intervals in Norwegian adults |
title | Updated total IgE reference intervals in Norwegian adults |
title_full | Updated total IgE reference intervals in Norwegian adults |
title_fullStr | Updated total IgE reference intervals in Norwegian adults |
title_full_unstemmed | Updated total IgE reference intervals in Norwegian adults |
title_short | Updated total IgE reference intervals in Norwegian adults |
title_sort | updated total ige reference intervals in norwegian adults |
topic | Short Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9753806/ https://www.ncbi.nlm.nih.gov/pubmed/36705407 http://dx.doi.org/10.1002/iid3.751 |
work_keys_str_mv | AT vinneserikwilhelm updatedtotaligereferenceintervalsinnorwegianadults AT skarbøbirthe updatedtotaligereferenceintervalsinnorwegianadults AT wentzellarsentore updatedtotaligereferenceintervalsinnorwegianadults AT syltemarits updatedtotaligereferenceintervalsinnorwegianadults AT apelsethtorunnoveland updatedtotaligereferenceintervalsinnorwegianadults |